关注ST段抬高型心肌梗死患者的合并症
Spotlight on comorbidities in STEMI patients.
作者信息
Bruno Raphael Romano, Kelm Malte, Jung Christian
机构信息
Division of Cardiology, Pulmonology, and Vascular Medicine Medical Faculty University Hospital Düsseldorf Dusseldorf Germany.
出版信息
Endocrinol Diabetes Metab. 2019 Nov 19;3(1):e00102. doi: 10.1002/edm2.102. eCollection 2020 Jan.
Mortality for myocardial infarction is at its lowest historical level for 20 years, but comorbidities such as anemia, renal failure and hyperglycemia seem the next frontier to investigate their impact as risk modifiers mortality in acute myocardial infarction. Stress hyperglycemia is a very frequent problem in STEMI, but continuous insulin infusion therapy (CIIT) resulted in >threefold and >twofold increased risks in-hospital and 1-year mortality, respectively.
心肌梗死的死亡率处于20年来的历史最低水平，但诸如贫血、肾衰竭和高血糖等合并症似乎是下一个需要研究其作为急性心肌梗死死亡风险修饰因素影响的领域。应激性高血糖在ST段抬高型心肌梗死（STEMI）中是一个非常常见的问题，但持续胰岛素输注治疗（CIIT）分别使住院死亡率和1年死亡率增加了三倍多和两倍多。
Zotero 插件